BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 1388591)

  • 1. Synthesis and cardiotonic activity of 2-substituted 5-cyano-1,6-dihydro-6-oxo-3-pyridinecarboxylic acids and their methyl or ethyl esters.
    Mosti L; Menozzi G; Schenone P; Dorigo P; Gaion RM; Belluco P
    Farmaco; 1992 Apr; 47(4):427-37. PubMed ID: 1388591
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and pharmacological activities of ethyl 5-cyano-1,6-dihydro-6-oxo-2-(2,3,4-pyridyl)-3-pyridinecarboxylates and derivatives.
    Mosti L; Schenone P; Mahiques MM; Dorigo P; Fraccarollo D; Santostasi G; D'Amico M; Falciani M; Lampa E
    Farmaco; 1994 Sep; 49(9):559-66. PubMed ID: 7811351
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inotropic agents. Synthesis and structure-activity relationships of new milrinone related cAMP PDE III inhibitors.
    Fossa P; Boggia R; Lo Presti E; Mosti L; Dorigo P; Floreani M
    Farmaco; 1997; 52(8-9):523-30. PubMed ID: 9507660
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and cardiotonic activity of novel pyrimidine derivatives: crystallographic and quantum chemical studies.
    Dorigo P; Fraccarollo D; Santostasi G; Maragno I; Floreani M; Borea PA; Mosti L; Sansebastiano L; Fossa P; Orsini F; Benetollo F; Bombieri G
    J Med Chem; 1996 Sep; 39(19):3671-83. PubMed ID: 8809156
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacological characterization of a new milrinone analogue.
    Dorigo P; Fraccarollo D; Santostasi G; Gaion RM; Maragno I; Floreani M; Carpenedo F; Jester M; Mosti L; Schenone P
    Farmaco; 1994 Jan; 49(1):19-23. PubMed ID: 8185745
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Potential cardiotonics. 14. Synthesis and in vitro positive inotropic actions of 4-morpholino-5-(4-pyridinyl)pyridine derivatives].
    Hagen V; Hagen A; Krause EG; Klauschenz E
    Pharmazie; 1992 Oct; 47(10):767-9. PubMed ID: 1480654
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An analysis of the mechanism of the inotropic action of some milrinone analogues in guinea-pig isolated atria.
    Dorigo P; Gaion RM; Belluco P; Mosti L; Borea PA; Maragno I
    Br J Pharmacol; 1991 Dec; 104(4):867-72. PubMed ID: 1810600
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Potential cardiotonic agents. 6. Synthesis and cardiovascular properties of 5-(4-pyridinyl)-, 6-methyl-5-(4-pyridinyl)- and 6-methyl-5-phenyl-substituted 3-cyano-2-oxaalkyoxy-pyridines].
    Hagen V; Klauschenz E; Rumler A; Hagen A; Heer S; Mitzner R; Niedrich H; Lohmann D
    Pharmazie; 1990 Mar; 45(3):189-90. PubMed ID: 2381960
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A pharmacological, crystallographic, and quantum chemical study of new inotropic agents.
    Dorigo P; Gaion RM; Belluco P; Fraccarollo D; Maragno I; Bombieri G; Benetollo F; Mosti L; Orsini F
    J Med Chem; 1993 Aug; 36(17):2475-84. PubMed ID: 8355248
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Potential cardiotonic agents. 4. Synthesis, cardiovascular activity, molecular and crystal structure of 5-phenyl- and 4-(4-pyridinyl)-substituted 2(1H)-pyridinethiones].
    Hagen V; Rumler A; Reck G; Hagen A; Labes D; Heer S
    Pharmazie; 1989 Dec; 44(12):809-13. PubMed ID: 2635317
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Different action of milrinone analogs in guinea-pig atria.
    Dorigo P; Gaion RM; Borea PA; Belluco P; Mosti L; Maragno I
    Gen Pharmacol; 1990; 21(4):511-5. PubMed ID: 2165957
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel milrinone analogs of pyridine-3-carbonitrile derivatives as promising cardiotonic agents.
    Bekhit AA; Baraka AM
    Eur J Med Chem; 2005 Dec; 40(12):1405-13. PubMed ID: 16040161
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A new milrinone analog: role of binding to A1 adenosine receptor in its positive inotropic effect on isolated guinea pig and rat atria.
    Floreani M; Borea PA; Gessi S; Mosti L; Fossa P; Dorigo P
    J Pharmacol Exp Ther; 1997 Nov; 283(2):541-7. PubMed ID: 9353368
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiovascular effects of the new cardiotonic agent 1,2-dihydro-6-methyl-2-oxo-5-(imidazo[1,2-a]pyridin-6-yl)-3-pyridine carbonitrile hydrochloride monohydrate. 1st communication: studies on isolated guinea pig cardiac muscles.
    Ogawa T; Ohhara H; Tsunoda H; Kuroki J; Shoji T
    Arzneimittelforschung; 1989 Jan; 39(1):33-7. PubMed ID: 2566308
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 3-Acetyl-5-acylpyridin-2(1H)-ones and 3-acetyl-7,8-dihydro-2,5(1H,6H)-quinolinediones: synthesis, cardiotonic activity and computational studies.
    Lo Presti E; Boggia R; Feltrin A; Menozzi G; Dorigo P; Mosti L
    Farmaco; 1999 Jul; 54(7):465-74. PubMed ID: 10486914
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selective inhibition of cAMP phosphodiesterase III activity by the cardiotonic agent saterinone in guinea pig myocardium.
    Brunkhorst D; von der Leyen H; Meyer W; Schmidt-Schumacher C; Scholz H
    Arzneimittelforschung; 1988 Sep; 38(9):1293-8. PubMed ID: 2852013
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vivo cardiotonic activity of pyridylmethylene-2-indolinones.
    Andreani A; Locatelli A; Morigi R; Leoni A; Bossa R; Chiericozzi M; Galatulas I
    Arzneimittelforschung; 1998 Jul; 48(7):727-9. PubMed ID: 9706372
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Potential cardiotonic agents. 1. Synthesis and pharmacologic properties of 3-cyano-2-oxaalkylamino-5-(4-pyridinyl)pyridines].
    Hagen V; Hagen A; Heer S; Mitzner R; Niedrich H
    Pharmazie; 1989 Jan; 44(1):20-3. PubMed ID: 2727022
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Positive inotropic activity of 5-amino-6-cyano-1,3-dimethyl-1,2,3,4-tetrahydropyrido[2,3-d]pyrim idine-2,4-dione in cardiac muscle from guinea-pig and man. Part 6: Compounds with positive inotropic activity.
    Heber D; Heers C; Ravens U
    Pharmazie; 1993 Jul; 48(7):537-41. PubMed ID: 7692456
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Synthesis and cardiotonic activity of pyrazolylpyrimidines].
    Sedereviciute V; Garaliene V; Vainilavicius P; Hetzheim A
    Pharmazie; 1998 Apr; 53(4):233-7. PubMed ID: 9583084
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.